Revive Therapeutics
  • Home
  • About
    • Management Team
    • Clinical Team
    • Board of Directors
  • Pipeline
    • Infectious Diseases
    • Intellectual Property
  • Investor
  • News
  • Contact
Select Page

Notice of Annual and Special Meeting Of Shareholders

Aug 19, 2022

  • Notice of Annual and Special Meeting Of Shareholders
  • Notice of Meeting and Management Information Circular for the Annual And Special Meeting of Shareholders to be held on September 19, 2022
  • Form of Proxy
  • Voting Instruction Form
  • Request for Financial Statements

Email Sign Up

Success!

Subscribe

Recent News

Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development

Feb 6, 2023

...

read more

Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch

Feb 3, 2023

...

read more

Revive Therapeutics Submits Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Jan 19, 2023

...

read more

Revive Therapeutics To Submit Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Jan 12, 2023

...

read more

Privacy Policy

Disclaimer

  • Facebook
  • Twitter
  • Instagram
© COPYRIGHT 2023. Revive Therapeutics Ltd. ALL RIGHTS RESERVED.